Health Topics — Women's Health
When Your Cycle Runs Your Life
For the woman whose period brings pain that cancels plans, disrupts sleep, and demands to be managed rather than lived through — what the biology shows and what the research has examined.
You probably track your cycle not to plan for it but to brace for it. The days before your period when everything feels heavier. The first day or two when the pain is bad enough to change your plans, your sleep, your ability to function normally. The way you've learned to structure your life around something that shouldn't require this much management.
You have been told this is normal. You may even believe it. But the level of pain that disrupts daily life — that requires more than a couple of ibuprofen and rest — deserves a biological explanation, not a dismissal.
Menstrual pain — what medicine calls dysmenorrhea — is one of the most common causes of recurring pain in women. For the majority, it involves manageable discomfort in the first day or two of bleeding. For a significant minority, it involves pain severe enough to interfere substantially with work, school, and daily life. The difference between these experiences isn't a matter of pain tolerance. It is a matter of biology — specifically, of how much prostaglandin the uterine lining produces and how sensitized the surrounding pain fibers have become.
Prostaglandins are the molecules that drive menstrual pain. They are released in large amounts as the endometrial lining breaks down during menstruation, causing the uterine muscle to contract powerfully and reducing blood flow to the uterus. Less blood flow means oxygen deprivation, and oxygen deprivation in muscle tissue is one of the most direct pain signals the body produces. The same prostaglandins also sensitize nearby pain receptors, meaning the already-painful signal gets amplified on its way to the brain. For women with endometriosis — where endometrial tissue grows outside the uterus and produces its own inflammatory environment — this pain system becomes significantly more complex and often more severe.
Where the endocannabinoid system comes in
The endocannabinoid system is present throughout uterine and reproductive tissue. CB1 and CB2 receptors are expressed in uterine smooth muscle, in the cells lining the uterus, and along the pain fibers that carry menstrual pain signals to the spinal cord. The body produces its own endocannabinoids in this tissue, and their levels fluctuate across the menstrual cycle — tracking hormonal changes, present most where and when they are needed most.
In plain terms: the body has its own system for moderating uterine contractions and pain signaling during menstruation. CB1 receptor activation in uterine smooth muscle has been shown preclinically to reduce contractility — the same mechanism through which the endocannabinoid system moderates muscle excitability elsewhere in the body. CB2 receptor activation in the immune cells of the uterine lining can reduce the inflammatory signals that drive prostaglandin production in the first place.
Research has also found that women with endometriosis have lower anandamide levels in the fluid surrounding their endometriotic lesions than women without the condition — suggesting that in the condition associated with the most severe menstrual pain, endocannabinoid tone is specifically reduced in the tissue where pain is produced. This is an observational finding, not a clinical outcome — but it is the most direct human evidence available that the endocannabinoid system is specifically implicated in this kind of pain.
What the research on CBG and CBD has examined
CBD slows the breakdown of anandamide — the body's own endocannabinoid — by inhibiting the enzyme that degrades it. In the context of menstrual pain, where anandamide availability appears to be specifically reduced in the tissue most affected, this mechanism is directly relevant. CBD also interacts with TRPV1 receptors on pain fibers, which are sensitized by prostaglandins during menstruation and which contribute to the amplification of pain signals. These are preclinical mechanisms — documented in laboratory settings, not in human menstrual pain trials.
CBG's relevant mechanisms are primarily anti-inflammatory: CB2 receptor activity in immune tissue, and PPAR-γ activation — a pathway that reduces the inflammatory gene programs driving prostaglandin production. In the context of menstrual pain, where the inflammatory cascade that produces prostaglandins is the primary driver, CBG's anti-inflammatory profile is biologically relevant even in the absence of menstrual-specific research.
No randomized controlled trial has tested CBD or CBG specifically for dysmenorrhea or endometriosis as of 2026. What exists is a coherent biological rationale — mechanisms that connect to the specific biology of menstrual pain in documented ways — and a pattern of widespread self-medication with cannabis for menstrual pain in surveys of women who report it helpful. Neither is a clinical outcome. Both are worth knowing.
On the evidence and on clinical care
The biological connections described here are real. The clinical trial evidence for cannabinoids in menstrual pain does not yet exist. We present the research in that proportion — the mechanisms are plausible and documented, the clinical outcomes are not established.
Severe menstrual pain and endometriosis are medical conditions that deserve proper clinical assessment. Effective conventional treatments exist for both. The research context here is relevant to understanding the evidence base — it is not a substitute for gynecological care.
What this means in practice
We can't tell you that a CBG or CBD preparation will reduce your menstrual pain. The research doesn't yet support that claim and we don't make it. What we can offer is the honest biological picture — the mechanisms through which these compounds interact with the specific systems involved in menstrual pain — so that if you're considering whether a whole-plant cannabinoid preparation is worth trying alongside whatever else you're doing, you have a grounded context for that consideration.
The preparations we make are whole-plant — the full botanical range of the hemp plant preserved through traditional alcohol maceration. We grow what we prepare. Every batch is independently tested. If you decide to try one in the context of your cycle, the research suggests that consistent use over time is more relevant than acute use on the days of worst pain alone — because the biological mechanisms involved are regulatory rather than immediately analgesic.
Future articles in this pillar examine the menstrual pain biology in deeper detail, what the research on the ECS in uterine tissue shows, and how CBG and CBD's mechanisms map specifically onto the prostaglandin pathway. If you want the fuller picture now, the research section is the place to start.
Pain that runs your life is not a character flaw or a failure of management. It is biology — specifically, prostaglandin biology operating in a body whose own pain-moderating systems may be working against the demands being placed on them. The endocannabinoid system is present in that biology in documented ways. The research on what CBG and CBD do in relationship to it is real and still developing. You deserve an honest account of what exists, and that is what this archive is for.
These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.